FILE - Food and Drug Administration (FDA) building is shown in Silver Spring, Md., Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File) (Manuel Balce Ceneta, Copyright ...
An estimated 25 million-plus American adults have social anxiety disorder, but the company's nasal spray is meant to act on-demand to quell fears. A nasal spray to combat social anxiety disorder ...
Please provide your email address to receive an email when new articles are posted on . Participants in the phase 3 trial were significantly less anxious during a public speaking challenge after ...
Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
The FDA has approved Spravato® (esketamine nasal spray; Janssen), in conjunction with an oral antidepressant, for the treatment of depressive symptoms in adults with major depressive disorder with ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, ...
A carry-with-you nasal spray may be able to treat bouts of paroxysmal supraventricular tachycardia (PSVT), a type of arrhythmia that affects nearly two million Americans each year. People who have ...
New Delhi: What began as a routine complaint of nasal blockage turned into one of the most extraordinary medical cases doctors at Manipal Hospital, Dwarka, ever encountered. A 33-year-old woman, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback